Stock comparison
Biogen
BIIB$30.72BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.11BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
BIIB 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
BIIB0wins
7winsSANOFICONR.NS
45D
B78
55D
A89
35F
B83
13F
B77
26F
A91
40F
A86
41F
A85
Side-by-side metrics
| Metric | BIIB | SANOFICONR.NS |
|---|---|---|
| Market cap | $30.72B | $104.11B Winner |
| P/E (TTM) | Winner: 21.2x | 44.2x |
| EV/EBIT | Winner: 17.3x | 31.8x |
| ROIC (TTM) | 5.44% | 59.15% Winner |
| Gross margin | Winner: 69.77% | 68.13% |
| Net margin | 13.92% | 27.35% Winner |
| Revenue CAGR 5y | -2.78% | 27.01% Winner |
| EPS CAGR 5y | -4.05% | 20.67% Winner |
| Debt / Equity | 0.4x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BIIB leads on
- P/E (TTM)21.2xvs 44.2x+52%
- EV/EBIT17.3xvs 31.8x+46%
SANOFICONR.NS leads on
- EPS CAGR 5y20.67%vs -4.05%+120%
- Revenue CAGR 5y27.01%vs -2.78%+110%
- ROIC (TTM)59.15%vs 5.44%+91%
- Debt / Equity0.1xvs 0.4x+82%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.